ITEAX
Price
$10.84
Change
+$0.04 (+0.37%)
Updated
Jul 3 closing price
Net Assets
287.74M
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

ITEAX vs VIVIX

Header iconITEAX vs VIVIX Comparison
Open Charts ITEAX vs VIVIXBanner chart's image
VY® T. Rowe Price Equity Income A
Price$10.84
Change+$0.04 (+0.37%)
VolumeN/A
Net Assets287.74M
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
ITEAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ITEAX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITEAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. ITEAX (288M). VIVIX pays higher dividends than ITEAX: VIVIX (2.19) vs ITEAX (1.40). ITEAX was incepted earlier than VIVIX: ITEAX (21 years) vs VIVIX (27 years). ITEAX (1.24) is less costly to investors than VIVIX (0.04). ITEAX is a more actively managed with annual turnover of: 21.00 vs. VIVIX (9.00). ITEAX has a lower initial minimum investment than VIVIX: ITEAX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. ITEAX (5.13). VIVIX return over 5 years is better than : 79.11 vs. ITEAX (48.29).
ITEAXVIVIXITEAX / VIVIX
Total Expense Ratio1.210.043,025%
Annual Report Gross Expense Ratio1.240.043,100%
Fund Existence21 years27 years-
Gain YTD6.9315.609124%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets288M189B0%
Annual Yield % from dividends1.402.1964%
Returns for 1 year5.1311.4145%
Returns for 3 years7.0934.4021%
Returns for 5 years48.2979.1161%
Returns for 10 years-17.35114.45-15%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc